Turning over a new leaf. by unknown
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place. The mollusks, which typically mea-
sure about one inch across, are able to filter
a liter of water a day. In a recent article
Lisk said, "They're quite effective at filter-
ing water and concentrating poisons. So
what you have is a monitor that sits there
and tells you what's happening."
Scientists at the Center for Great Lakes
Studies and the University ofWisconsin in
Milwaukee are excited about the mollusks'
filtering abilities for another reason. In a
laboratory experiment using zebra mussels
to form a filter, the mussels reduced quan-
tities of cryptosporidium by more than
95%. (Crytosporidium is a parasite that
made hundreds of people sick last year
when it contaminated Milwaukee's water
system.) The zebra mussels also reduced
coliform bacteria by 69%, most other bac-
teria in the water by 75%, and removed
almost all particulate matter. Although the
scientists conducting the experiment envi-
sion using full-scale zebra mussel filters at
municipal water plants, there are currently
no plans to implement the idea.
The environmental benefit of zebra
mussels, however, may not outweigh the
harm they cause to water systems, and the
mollusks may inadvertently cause the
introduction ofeven more contaminants to
water supplies. Environmental officials
estimate that the rapid spread of zebra
mussels will cause up to $5 billion in prop-
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Changing its stripes. Scientists are developing positive uses for zebra mussels.
erty damage. Worse than that, say some, is
the fact that currently the only effective
means of controlling zebra mussels is to
add chlorine or other chemicals into the
pipes to kill the larvae before they attach,
thereby introducing a new set of health
concerns into the picture. Still, adds Lisk
optimistically, until someone figures out a
way to get rid of zebra mussels, we might
as well make productive use ofthem.
Turning over a New Leaf
Reviled by doctors as the killer crop, tar-
geted by antismoking activists, and investi-
gated by Congress and the FDA for poten-
tial drug regulation, tobacco has become a
popular nemesis in the past few years. New
experiments suggest, however, that tobac-
co's nasty reputation may be cleaned up if
the plant's promise as a medicine producer
is fulfilled.
Although many of the almost 4,000
chemicals in tobacco are dangerous, others
have beneficial or commercial use. For
instance, scientists at North Carolina State
University, in the country's top tobacco-
producing state, are using tobacco plants
to produce fraction-1, a protein produced
by all green vegetables, but made in higher
concentrations in tobacco. Although the
first application ofthe gelatinous substance
will probably be in cosmetics, researchers
hope the protein may have potential as a
nonallergenic infant formula or as an ultra-
pure food for kidney patients that may
help them to avoid dialysis.
'What has scientists truly excited about
tobacco, however, is not so much the sub-
stances the plant produces naturally, but
the medicines it may be engineered to
make in the future, including blood thin-
ners and possibly a drug to battle AIDS.
Tobacco grows foreign genes so easily that
scientists hope it may one day replace
expensive transgenic animals and bacterial
systems now being engineered to produce
human proteins. "Tobacco is like the white
mouse of the plant world," said Bob
Erwin, president of BioSource Genetics, a
new company investigating pharmaceutical
tobacco, in an article by the Associated
Press. Erwin has infected plants with trans-
genic viruses to produce a molecule called
alpha-trichosanthin, which is being tested
as a possible AIDS drug. The hope is that
the plants will synthesize the substance in
far greater amounts than humans synthe-
size it, making the drug more accessible
and less expensive.
Plant pathologist Carole Cramer and
colleague Deb Weissenborn of Virginia
Technical Institute are conducting field
trials at the Southern Piedmont Agri-
cultural Experiment Station in Blackstone,
Virginia, on tobacco plants bioengineered
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to express a bacterial gene used to produce
a human anticoagulant. Cramer infected
tobacco leaf with the bacteria and used it
to grow dozens of transgenic plants pro-
ducing the human blood protein. She is
now extracting the protein and testing it to
see if it has the same qualities as protein
produced by humans. Although it may be
years before any direct medicinal benefit is
derived from tobacco, scientists are pre-
dicting that these new uses may be the sav-
ior of the small tobacco farmer and turn
tobacco from an instrument ofharm to an
instrument ofhealing.
Cyber-schnoz
To find answers to difficult questions, peo-
ple have, for years, been exhorted to follow
their noses. Scientists seeking to under-
stand how environmental toxins affect ani-
mals and people have taken this statement
literally-well, almost. Researchers at the
Chemical Industry Institute ofToxicology
are using an innovative new tool-a com-
puter-generated rat's nose-to study the
effects ofchemicals.
Toxicologists studying rat inhalation
have found that how a chemical toxin
affects an animal, or possibly a person,
depends, in part, on where the chemical
deposits in the respiratory system. Because
inhalation studies are expensive and diffi-
cult because of the numbers of animals
required, researchers began to look for
another way to get the same information,
thus the cyber-schnoz. Kevin Morgan, a
biologist and veterinarian, and Julie
Kimbell, who holds a Ph.D. in differential
geometry, worked for five months at CIIT,
a not-for-profit, industry-funded toxicolo-
gy laboratory, developing a three-dimen-
sional computer model of the inside of a
three-month-old rat's right nostril.
Using the finite elemental method of
solving complex geometrical equations and
more than 600 slides of rat nasal passages,
Morgan and Kimbell devised a model of
the virtual reality nose that allows them to
simulate air carrying environmental toxins
throughout the nasal passages. So far, they
have used the model to examine where
chemicals such as formaldehyde and ozone
deposit in the nasal passages. According to
Morgan, they hope to eventually use the
model to study all types of reactive gases,
vapors, and particles. They hope to be able
to extrapolate this information to tell how
these chemicals may affect the human res-
piratory system.
Morgan and Kimbell use two different
methods to judge the accuracy ofthe infor-
mation generated by the computer nose. In
the first method, they compare the uptake
pattern ofthe distribution offormaldehyde
generated by the computer with actual pat-
terns of nasal lesions in rats exposed to
formaldehyde. In the second method,
photo developer is poured into a laboratory
flow tank containing a geometric pattern
on film which simulates the rat nasal pas-
sages. The rate ofdevelopment ofthe film
creates a pattern that the researchers can
correlate with the computer simulation to
test its validity. Regarding the rate ofcorre-
lation, Morgan said, "We've found it to be
extremely good."
Still, the "technose" has
its limitations. For this rea-
son, Morgan and Kimbell are
working to develop human
and rhesus monkey comput-
er nose models. The human
nose project used magnetic
resonance imaging and CAT
scans to generate the neces-
sary coordinates. According
to Morgan, who is working
primarily on this project,
they are now ready to begin
constructing a model. The
rhesus monkey nose model,
being developed through a
cooperative agreement with
the EPA, is much further
along. Kimbell has begun
the first air flow tests on the
rhesus monkey nose, which
is much larger and much
more similar to a human
nose than the rat's. Said
Morgan, "The monkey is a
good intermediate between
the rat and human." At least
some laboratory rats can now breathe a sigh
ofrelief.
Age-old Genetic Questions
Knowing that tumor incidence increases
with age and that certain gene mutations
are critical events in tumor formation, sci-
entists have long supposed that genetic
mutations leading to cancer increase with
age. Until recently there was no direct evi-
dence ofthis hypothesis, but researchers at
the University ofSouthern California have
now demonstrated that mutations in the
oncogenes responsible for non-Hodgkin's
lymphoma accumulate over the lifetimes of
some individuals, perhaps putting them at
greater risk for developing cancer.
"Age is the single most significant risk
factor for cancer, and the incidence ofmost
cancers rises exponentially with age, said
Gino A. Cortopassi, assistant professor of
molecular pharmacology and toxicology at
the USC School of Pharmacy who led the
experiment, in an article by the Associated
Press. Knowing that the incidence of non-
Hodgkin's lymphoma increases over 40-
fold with age, Cortopassi and colleagues
used a technique called polymerase chain
reaction to examine peripheral blood lym-
phocytes from 53 live patients and 31
autopsies, none of whom had non-Hodg-
kins lymphoma. The team was looking for
translocation mutations in the BCL2 (B-
cell leukemia/lymphoma-2) gene known to
be associated with the disease. The muta-
tions are found in about halfofall cases of
non-Hodgkin's lymphoma.
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